ACN Newswire
Read More

Handover of National Centre for Pandemic and Infection Diseases in Myanmar; Advanced Facility Built with Donation from AW Foundation

indie
3 minutes

YANGON, Myanmar, Nov 5, 2022 - (ACN Newswire via SEAPRWire.com) - AW Foundation, the philanthropic arm of Asia World Group of Companies, handed over to the Ministry of Health the newly completed Wai Bar Gi New Wing - National Centre for Infectious Diseases on 3rd Nov, 2022. Dedicated to the treatment of infectious diseases and pandemics such as COVID-19 which exerted heavy patient load on the public healthcare sector, it is the most advanced medical centre to date in Myanmar. The Newly-Constructed Wai Bar Gi New Wing- National Centre for Infectious DiseasesSide Views of Wai Bar Gi New Wing- National Centre for Infectious Diseases Interior Views of Wai Bar Gi New Wing- National Centre for Infectious Diseases Lieutenant General Aung Lin Dwe, the secretary of the State Administration Council, unveiled a plaque commemorating the handover of the three-story, 110-bed medical Centre, which was completed with a donation of 6 billion kyats and USD 3.1 million from the Foundation.The Wai Bar Gi New Wing was mooted in November 2020 by the AW Foundation team based on the personal experience of colleagues during the COVID-19 pandemic. The lack of quarantine hospitals, beds, and oxygen supply, a...

JCN Newswire
Read More

Shionogi and NEC Enter into Strategic Research Collaboration for Novel Hepatitis B Therapeutic Vaccine

ruth
4 minutes

OSAKA, Japan and TOKYO, Japan, Apr 18, 2022 - (JCN Newswire via SEAPRWire.com) - Shionogi & Co., Ltd. and NEC Corporation, today announced the execution of a strategic research collaboration agreement for the development of a novel hepatitis B therapeutic vaccine. NEC OncoImmunity, an NEC subsidiary that specializes in artificial intelligence-driven biotechnology, is also participating in this research collaboration. Hepatitis B is a potentially life-threatening liver disease caused by the hepatitis B virus (HBV). Chronic infection with HBV results in a high risk of death from cirrhosis and liver cancer. About 300 million people are living with chronic hepatitis B infection worldwide, and hepatitis B resulted in an estimated 820,000 deaths in 20191. Although the widespread use of hepatitis B vaccines in infants has considerably reduced the incidence of new chronic HBV infections under the age of 5, the number of new infections by other routes continues to increase2. Interferon (IFN) and nucleotide analog therapy are currently used in the treatment of hepatitis B. However, treatment with IFN has a high frequency of side effects, and nucleotide analog therapy has a high recurrenc...

SeaPRwire
Read More

Morning Briefing: Top stories from The Straits Times on Jan 7

aseanpr
2 minutes

Good morning! Here are our top stories to kick-start your Thursday, Jan 7. Woman shot inside US Capitol dies after pro-Trump protesters storm building The city is under curfew and the National Guard has been deployed after protesters stormed barricades. READ MORE HERE Democrats gain control of US Senate with wins in Georgia Jon Ossoff was proclaimed the winner in the second of two Senate runoff races. READ MORE HERE America's toxic divide explodes and anger likely to remain The US is a tinderbox with a population deeply divided, says US bureau chief Nirmal Ghosh. READ MORE HERE More on this topic Related Story ST newsletters: Get alerts on the latest news Hongkongers shocked and divided by arrests of pro-democracy leaders The city's pro-Beijing lawmakers welcomed the arrests but others see it as a purge of the opposition. READ MORE HERE NUS had 71 complaints of sexual misconduct involving students in past five years The number was highest in 2019, when 25 such reports were made. READ MORE HERE Korean man who works at Crowne Plaza Changi Airport among 2 new unlinked Covid-19 community cases in S'pore A preliminary test showed he was positive for the more infectious UK strain of Covi...